WALTHAM, Mass., Nov. 7 /PRNewswire-FirstCall/ -- Thermo Electron Corporation announced that it will present at the New York Stock Exchange Health Care Conference on Tuesday, November 15, 2005 at 8:50 a.m. (GMT) (3:50 a.m. EST) at Haberdasher’s Hall in London.
Marijn E. Dekkers, president and chief executive officer of Thermo Electron, will give an overview of Thermo Electron and discuss its expectations for future financial performance.
Mr. Dekkers’ presentation will be audio Webcast live at http://www.thermo.com -- click on “About Thermo,” then “Investors.” An audio archive of the presentation will remain available on the company’s Website until Thursday, December 15, 2005. Click on “Audio Archives” under “Presentations” at http://www.thermo.com.
About Thermo Electron
Thermo Electron Corporation is the world leader in analytical instruments. Our instrument solutions enable our customers to make the world a healthier, cleaner and safer place. Thermo’s Life and Laboratory Sciences segment provides analytical instruments, scientific equipment, services and software solutions for life science, drug discovery, clinical, environmental and industrial laboratories. Thermo’s Measurement and Control segment is dedicated to providing analytical instruments used in a variety of manufacturing processes and in-the-field applications, including those associated with safety and homeland security. Based near Boston, Massachusetts, Thermo has revenues of more than $2.7 billion, and employs approximately 11,000 people in 30 countries. For more information, visit http://www.thermo.com.
Media Contact Information: Investor Contact Information: Lori Gorski Kenneth J. Apicerno Phone: 781-622-1242 Phone: 781-622-1111 E-mail: lori.gorski@thermo.com E-mail: investorrelations@thermo.com Website: http://www.thermo.com
Thermo Electron Corporation
CONTACT: Lori Gorski, +1-781-622-1242, lori.gorski@thermo.com, or KennethJ. Apicerno, +1-781-622-1111, investorrelations@thermo.com, both of ThermoElectron Corporation
Web site: http://www.thermo.com//
Company News On-Call: http://www.prnewswire.com/comp/877850.html/
